Header cover image

French Pharmaceuticals & Biotech Buy the Dip

Results

1

1 new

Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.

1 companies

Cellectis

Market Cap: €184.6m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.

New

ALCLS

€2.54

7D

-9.9%

1Y

53.1%